A biotech company approached Science 37 to swiftly recruit, enroll, and treat a targeted population of participants across the United States. The study was unique due to the challenge of carefully monitoring and tracking the COVID-19 virus and determining where hot spots would occur.
Download the case study to learn how Science 37 delivered:
- Enhanced patient recruitment
- Expedited trial initiation and operation
- Enrollment that closely mirrored census guidelines